A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Silk Road Medical Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 732,900 shares of SILK stock, worth $20.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
732,900
Previous 756,000 3.06%
Holding current value
$20.1 Million
Previous $13.8 Million 43.09%
% of portfolio
0.05%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.95 - $27.04 $391,545 - $624,624
-23,100 Reduced 3.06%
732,900 $19.8 Million
Q1 2024

May 15, 2024

BUY
$11.38 - $19.03 $1.12 Million - $1.88 Million
98,600 Added 15.0%
756,000 $13.8 Million
Q4 2023

Feb 14, 2024

BUY
$6.29 - $15.72 $1.46 Million - $3.66 Million
232,900 Added 54.86%
657,400 $8.07 Million
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $2.14 Million - $4.66 Million
142,800 Added 50.69%
424,500 $6.36 Million
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $4.17 Million - $6.46 Million
140,100 Added 98.94%
281,700 $9.15 Million
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $4.94 Million - $7.5 Million
129,700 Added 1089.92%
141,600 $5.54 Million
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $482,426 - $668,780
11,900 New
11,900 $628,000
Q3 2021

Nov 15, 2021

SELL
$44.0 - $65.8 $2.32 Million - $3.47 Million
-52,700 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$44.66 - $63.06 $120,581 - $170,262
-2,700 Reduced 4.87%
52,700 $2.52 Million
Q1 2021

May 17, 2021

BUY
$46.31 - $62.7 $2.24 Million - $3.03 Million
48,300 Added 680.28%
55,400 $2.81 Million
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $394,121 - $496,574
7,100 New
7,100 $447,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.